INFORECERCA: Butlletí Informatiu del Servei de Recerca de l'IMIM
Número: 463
23/06/2016
Projectes
Termini exhaurit
BRAIN & BEHAVIOR RESEARCH FOUNDATION
The Brain & Behavior Research Foundation is the largest philanthropic organization dedicated to research across all brain and behavior disorders (not disease specific). Recipients of NARSAD Grants represent an extraordinary variety of disciplines. Research has included (but is not limited to) studies in: genetics, neurobiology, molecular biology, imaging, neurochemical studies, neurophysiology, electrophysiology, clinical psychopharmacology, descriptive clinical studies, epidemiological research, treatment modalities, cognition studies, and outcome and prevention research.
 
Termini exhaurit
DANONE INSTITUTE INTERNATIONAL
Proposals are requested for projects focused on health benefits associated with yogurt consumption. Research focused in the following areas are particularly encouraged:
  • mechanisms of action
  • pediatric populations
  • live microbes and milk fermentation benefits.
    The grant is supported by Danone Institute International in collaboration with the American Society for Nutrition (ASN) and the International Osteoporosis Foundation (IOF)
  •  
    Borses de viatge
    Termini exhaurit
    EUROPEAN ASSOCIATION FOR CANCER RESEARCH
    The EACR Travel Fellowship Programme is specifically designed to assist early career researchers to advance their research.
    Funding awards are made to support visits to work in centres of excellence, or to support attendance at specialised practical workshops and courses.
     
    Premis
    Termini exhaurit
    AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR)
    This lectureship will recognize an individual scientist whose novel and significant work has had or may have a far-reaching impact on the detection, diagnosis, treatment, or prevention of cancer.
     
    Termini exhaurit
    AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR)
    The AACR and the American Cancer Society established this award in 1992 to honor outstanding research accomplishments in the fields of cancer epidemiology, biomarkers, and prevention.
     
    Termini exhaurit
    AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR)
    The prestigious Pezcoller Foundation–AACR International Award for Cancer Research was established in 1997 to annually recognize a scientist of international renown:
  • who has made a major scientific discovery in basic cancer research OR who has made significant contributions to translational cancer research;
  • who continues to be active in cancer research and has a record of recent, noteworthy publications; and
  • whose ongoing work holds promise for continued substantive contributions to progress in the field of cancer.
    The award is intended to honor an individual scientist. However, more than one scientist may be co-nominated and selected to share the award when their investigations are closely related in subject matter and have resulted in work that is worthy of the award.
  •  
     
     
    Informació últil
     
     No hi ha novetats
     
     
    Banner-convocatories-tancament-02
    Projectes
    Termini exhaurit
    INNOVATIVE MEDICINES INITIATIVE
    IMI is a partnership between the European Union and the European pharmaceutical industry, represented by the European Federation of Pharmaceutical Industries and Associations (EFPIA).
    The goal of the Innovative Medicines Initiative 2 (IMI 2) is to develop next generation vaccines, medicines and treatments, such as new antibiotics. It will build on the successes and lessons learnt under IMI. Like IMI, it will bring together companies, universities, public laboratories, innovative small and medium-sized enterprises (SMEs), patient groups and regulators in collaborative projects that will pave the way for breakthrough vaccines, medicines and treatments to tackle Europe’s growing health challenges, and secure the future international competitiveness of Europe’s pharmaceutical industry.
     
    Termini exhaurit
    FEDER - FEDER
    Fomentar el desenvolupament de la recerca en l'àmbit de les malalties poc freqüents mitjançant el finançament de projectes de recerca.
    Tindran caràcter de recerques objecte d'aquesta convocatòria la recerca básica i translacional.
    Es consideren malalties rares o poc freqüents aquelles que compleixen els paràmetres de prevalença reconeguts internacionalment, és a dir que compleixen dos criteris:
    1) la prevalença acceptada per la Unió Europea de 5 o menys casos per 10.000 habitants, i
    2) que la malaltia estigui inclosa en les bases de dades Orphanet (www.orpha.net) o OMIM (www.ncbi.nlm.nih.gov/omim) amb nombre ORPHA o OMIM assignat.
     
    Termini exhaurit
    BRAIN & BEHAVIOR RESEARCH FOUNDATION
    The Brain & Behavior Research Foundation is the largest philanthropic organization dedicated to research across all brain and behavior disorders (not disease specific). Recipients of NARSAD Grants represent an extraordinary variety of disciplines. Research has included (but is not limited to) studies in: genetics, neurobiology, molecular biology, imaging, neurochemical studies, neurophysiology, electrophysiology, clinical psychopharmacology, descriptive clinical studies, epidemiological research, treatment modalities, cognition studies, and outcome and prevention research.
     
    Termini exhaurit
    DEMENTIA CONSORTIUM
    The Dementia Consortium aims to expedite the development of new drugs for dementia by supporting research into novel targets for neurodegeneration. It brings together the voluntary, academic and private sectors in order to tackle the growing dementia problem. The Consortium seeks to end the ten-year wait for a new dementia treatment by closing the gap between fundamental academic research and the pharmaceutical industry’s drug discovery programmes. It provides funding, expertise and resources to support new drug targets emerging from academic research that hold the promise of patient benefit.
     
    Termini exhaurit
    MINECO - MINISTERIO DE ECONOMÍA Y COMPETITIVIDAD
    Amb el finançament de les Xarxes d'Excel·lència es pretén que els grups participants en aquestes xarxes puguin tant planificar activitats conjuntes futures com consolidar resultats d'activitats de R+D+I anteriors, incloent aquelles desenvolupades en el marc dels Campus d'Excel·lència Internacional. També es pretén oferir suport a les activitats de promoció internacional i posicionament estratègic, mitjançant l'optimització de resultats i recursos, amb la vocació de situar la recerca espanyola, com a eix fonamental de desenvolupament econòmic i social, en l'avantguarda de la ciència i la tecnologia, tant a nivell nacional com internacional. La finalitat d'aquestes accions de dinamització és impulsar la internacionalització de les activitats de R+D i contribuir a l'avanç del coneixement per afrontar els desafiaments que la recerca espanyola té en el context de l'Espai Europeu de Recerca.
     
    Termini exhaurit
    RecerCaixa 2017
    La convocatòria d’ajuts a la recerca RecerCaixa finançarà projectes de recerca desenvolupats per investigadors i investigadores de les universitats i centres de recerca de Catalunya.
    La convocatòria persegueix principalment dos objectius: impulsar la recerca científica d'excel·lència al nostre país i acostar la ciència a la societat, fent-la partícip dels avenços científics i dels beneficis humans i socials.
     
    Termini exhaurit
    SOCIEDAD ESPAÑOLA DE NEUROLOGIA
    Beca dirigida a neuròlegs amb trajectòria de recerca acreditada, per a projectes de recerca en Neurosonologia que no comptin amb finançament de tercers.
     
    Termini exhaurit
    THE SUSAN G. KOMEN BREAST CANCER FOUNDATION
    Career Catalyst (CCR) Grants are intended to foster promising breast cancer researchers who are in the early stages of their faculty careers by providing support for up to three years of “protected time” for research career development under the guidance of a Mentor Committee. It is expected that awardees will launch independent research careers and successfully compete for subsequent research project funding in breast cancer following the successful completion of a CCR Grant, thereby playing key roles in reducing breast cancer incidence and mortality within the next decade, with the ultimate goal of ending breast cancer forever.
     
    Termini exhaurit
    THE SUSAN G. KOMEN BREAST CANCER FOUNDATION
    Career Catalyst (CCR) Grants are intended to foster promising breast cancer researchers who are in the early stages of their faculty careers by providing support for up to three years of “protected time” for research career development under the guidance of a Mentor Committee. It is expected that awardees will launch independent research careers and successfully compete for subsequent research project funding in breast cancer following the successful completion of a CCR Grant, thereby playing key roles in reducing breast cancer incidence and mortality within the next decade, with the ultimate goal of ending breast cancer forever.
     
    Termini exhaurit
    FUNDACIO LA CAIXA
    L'objecte de la present convocatòria és la tutoria de projectes de valorització dels actius resultants de la investigació, per al seu trasllat al mercat, ja sigui com un spin-off o com un acord de transferència, que requereixen la validació i desenvolupament de la seva proposta de generació de valor.
    Més específicament, el programa donarà suport a projectes de les àrees de la Vida, Medicina i Ciències de la Salut proposades pels centres, basats en actius per als quals s'ha sol·licitat o serà sol·licitada una patent o model d'utilitat, i destinats a afegir valor per a la seva transferència al mercat.
    Dins les àrees de la Vida, Medicina i Ciències de la Salut, es tindran en compte els projectes dels següents camps:
  • Ciències de la Vida: Biomatemàtica, Biologia Cel·lular, Biologia Humana, Bioquímica i Biologia Molecular, Fisiologia Humana, Genètica, Immunologia, Microbiologia i Neurociències.
  • Ciències Mèdiques i de la Salut: Ciències Clíniques, Epidemiologia, Medicina Forense, Medicina del treball, Medicina Interna, Ciències de la nutrició, Patologia, Farmacodinàmica, Farmacologia, Medicina Preventiva, Psiquiatria, Salut Pública, Cirurgia i Toxicologia.
  •  
    Termini exhaurit
    FRIEDREICH'S ATAXIA RESEARCH ALLIANCE
    FARA supports research through funding competitive grants, promoting collaboration among scientists, advocating for public-private partnerships that support drug discovery, drug development and clinical research and hosting open forums for leading scientists to share their insights, ideas and challenges to advancing treatments for FA.
     
    Altres
    Termini exhaurit
    BIOCAT - FUNDACIÓ PRIVADA BIOREGIÓ DE CATALUNYA
    Impulsar trobades internacionals d’alt nivell científic per promoure la col·laboració i l’intercanvi d’iniciatives i coneixements entre experts de reconegut prestigi i la comunitat científica catalana, generant debat avançat transversal en l’àmbit de les ciències de la vida i la seva repercussió a la societat.
     
    Borses de viatge
    Termini exhaurit
    UICC-GLOBAL CANCER CONTROL
    Union for International Cancer Control (UICC) is a membership organisation that exists to help the global health community accelerate the fight against cancer.
    Founded in 1933 and based in Geneva, UICC’s growing membership of over 900 organisations across 155 countries, features the world’s major cancer societies, ministries of health, research institutes and patient groups. Together with its members, key partners, the World Health Organization, World Economic Forum and others, UICC is tackling the growing cancer crisis on a global scale.
     
    Premis
    Termini exhaurit
    BIOIBÉRICA - BIOIBERICA SA
    Reconèixer aquells projectes o iniciatives innovadores que contribueixin a millorar la gestió de l'artrosi i la qualitat assistencial als pacients, tant en l'àmbit de l'atenció primària com en el de l'atenció hospitalària.
     
    Termini exhaurit
    PSICOFUNDACION - FUNDACIÓN ESPAÑOLA PARA LA PROMOCIÓN Y EL DESARROLLO CIENTÍFICO Y PROFESIONAL DE LA PSICOLOGÍA
    Des de PSICOFUNDACIÓN es pretén aconseguir que sorgeixin idees novedoses tant en la recerca com en l'aplicació pràctica de la ciència psicològica, donant suport a l'esperit emprenedor i innovador dels joves psicòlegs.
     
    Termini exhaurit
    SOCIETAT CATALANA DE CIRURGIA
    Premiar la tasca d'un cirurgià de dins i de fora de l'Estat Espanyol, en reconeixement dels mèrits obtinguts al llarg de la seva vida professional.
     
    Recursos Humans
    Termini exhaurit
    FUNDACIÓN TATIANA PÉREZ DE GUZMÁN EL BUENO
    Convocar 5 beques/contractes predoctorals en Neurociència per a espanyols que vagin a realitzar la seva tesi doctoral en un Programa de doctorat acreditat oficialment a Espanya.
    L'objectiu de les beques/contractes és la realització de la tesis doctoral en Neurociència enfocada a la comprensió del sistema nerviós humà i de les malalties que l'afecten.
     
    Termini exhaurit
    BAYER
    Bayer's mission is to provide new treatment options for diseases with high unmet medical need.
    The Bayer Fellowship Program targets students and apprentices in scientific and medical disciplines. Its goal is to support the next generation of researchers and teachers as they engage in “Science for a Better Life”.
     
    Termini exhaurit
    THE SUSAN G. KOMEN BREAST CANCER FOUNDATION
    Postdoctoral Fellowship (PDF) Grants are intended to attract and support promising scientists and clinician/scientists who are embarking on careers dedicated to breast cancer research. By providing funding to outstanding postdoctoral/postgraduate fellows under the guidance of a mentor, Komen seeks to ensure that a diverse pool of highly trained scientists will emerge as the next generation of leaders in the field of breast cancer research. These leaders will play key roles in reducing breast cancer incidence and mortality within in the next decade, with the ultimate goal of ending breast cancer forever.
     
    Termini exhaurit
    THE SUSAN G. KOMEN BREAST CANCER FOUNDATION
    Postdoctoral Fellowship (PDF) Grants are intended to attract and support promising scientists and clinician/scientists who are embarking on careers dedicated to breast cancer research. By providing funding to outstanding postdoctoral/postgraduate fellows under the guidance of a mentor, Komen seeks to ensure that a diverse pool of highly trained scientists will emerge as the next generation of leaders in the field of breast cancer research. These leaders will play key roles in reducing breast cancer incidence and mortality within in the next decade, with the ultimate goal of ending breast cancer forever.
     
     
     
     
    Articles
     
    Fernandez-Luque L, Mejova Y, Mayer MA, Hasvold PE, Joshi S. Panel: Big Data & Social Media for Empowering Patients with Diabetes. Stud Health Technol Inform 2016; 225: 607-609.
     
    Zamora E, Lupón J, Enjuanes C, Pascual-Figal D, de Antonio M, Domingo M, Comín J, Vila JS, Peñafiel J, Farré N, Alonso N, Santesmases J, Troya M, Bayés-Genís A*. No benefit from the obesity paradox for diabetic patients with heart failure. Eur J Heart Failure 2016; 18(7): 851-858.
     
    Vinyoles M, del Valle-Pérez B, Curto J, Padilla M, Villarroel A, Yang J, García de Herreros A*, Duñach M*. Activation of CK1? by PP2A/PR61? is required for the initiation of Wnt signaling. Oncogene 2017; 36(3): 429-438.
     
    Gimeno J, Redondo D, Pérez-Sáez MJ, Naranjo-Hans D, Pascual J*, Crespo M. Impact of the Banff 2013 classification on the diagnosis of suspicious versus conclusive late antibody-mediated rejection in allografts without acute dysfunction. Nephrol Dial Transplant 2016; 31(11): 1938-1946.
     
    Rabella M, Grasa E, Corripio I, Romero S, Mañanas MÀ, Antonijoan RM, Münte TF, Pérez V, Riba J*. Neurophysiological evidence of impaired self-monitoring in schizotypal personality disorder and its reversal by dopaminergic antagonism. Neuroimage Clin 2016; 11: 770-779.
     
    Kotronoulas A, Gómez-Gómez A, Segura J, Ventura R, Joglar J, Pozo O*. Evaluation of two glucuronides resistant to enzymatic hydrolysis as markers of testosterone oral administration. J Steroid Biochem & Mol Biol 2017; 165(Pt B): 212-218.
     
    Oliveras A*, Armario P, Clará A, Sans-Atxer L, Vázquez S, Pascual J, de la Sierra A. Spironolactone versus sympathetic renal denervation to treat true resistant hypertension: results from the DENERVHTA study - a randomized controlled trial. J Hypertens 2016; 34(9): 1863-1871.
     
    Gyarmati G, Turner MC*, Castaño-Vinyals G, Espinosa A, Papantoniou K, Alguacil J, Costas L, Pérez-Gómez B, Martin-Sanchez V, Ardanaz E, Moreno V, Gómez-Acebo I, Fernández-Tardón G, Villanueva V, Capelo R, Chirlaque MD, Santibáñez M, Pollán M, Aragonés N, Kogevinas M*. Night shift work and stomach cancer risk in the MCC-Spain study. Occup Environ Med 2016; 73(8): 520-527.
     
    Dávila-Seijo P*, Daudén E, Carretero G, Ferrándiz C, Vanaclocha F, Gómez-García FJ, Herrera-Ceballos E, De la Cueva-Dobao P, Belinchon I, Sánchez-Carazo JL, Alsina M, López-Estebaranz JL, Ferran M, Torrado R, Carrascosa JM, Llamas M, Rivera R, Jiménez-Puya R, García-Doval I, BIOBADADERM Study Group. Survival of classic and biological systemic drugs in psoriasis: results of the BIOBADADERM registry and critical analysis. J Eur Acad Dermatol Venereol 2016; 30(11): 1942-1950.
     
    Rodríguez-Nóvoa S, García-Samaniego J, Prieto M, Calleja JL, Pascasio JM, Delgado M, Crespo J, Butí M, Bonet-Vidal ML, Arenas J, Fernández-Rodríguez C, Solà R, Fraga E, González-Diéguez L, Nuñez O, Praga M, del Pino J, Romero-Gómez M, Morillas R, Diago M, Castro A, MENTE Study Group. Altered Underlying Renal Tubular Function in Patients With Chronic Hepatitis B Receiving Nucleos(t)ide Analogs in a Real-World Setting: The MENTE Study. J Clin Gastroenterol 2016; 50(9): 779-789.
     
    Bravo A, Li TS, Su AI, Good BM, Furlong LI*. Combining machine learning, crowdsourcing and expert knowledge to detect chemical-induced diseases in text. Database (Oxford) 2016; 2016: baw094.
     
    Mularoni L, Sabarinathan R, Deu J, González-Pérez A, López-Bigas N*. OncodriveFML: a general framework to identify coding and non-coding regions with cancer driver mutations. Genome Biol 2016; 17: 128.
     
     
    Tel: 93 316 04 00
    Doctor Aiguader, 88
    08003 Barcelona
    Seguiu-nos a:
    Twitter
    Youtube
    En compliment de la Llei 34/2002, de Serveis de la Societat de la Informació i de Comerç Electrònic, aquest correu li hem enviat a partir de les dades de contacte que vostè ens ha facilitat. Si vostè no desitja rebre més comunicats, pot donar-se de baixa dirigint-se per escrit al Servei de Recursos Humans-IMIM (RRHHconfidencialitat@imim.es) tot indicant la paraula “baixa base de dades” a l’assumpte.
    Li recordem que podrà exercir els drets d’accés, rectificació, cancel·lació i oposició dirigint-se per escrit al Servei de Recursos Humans-IMIM (RRHHconfidencialitat@imim.es).